HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yue-Ming Wang Selected Research

vertilmicin

10/2009In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yue-Ming Wang Research Topics

Disease

12Neoplasms (Cancer)
11/2021 - 10/2008
3Hepatocellular Carcinoma (Hepatoma)
06/2010 - 10/2008
2Type 2 Diabetes Mellitus (MODY)
02/2010 - 01/2009
1Lung Neoplasms (Lung Cancer)
04/2020
1Neoplasm Metastasis (Metastasis)
05/2019
1Glioblastoma (Glioblastoma Multiforme)
01/2019
1Esophageal Neoplasms (Esophageal Cancer)
09/2018
1Chemical and Drug Induced Liver Injury
11/2014
1Peripheral Nervous System Diseases (PNS Diseases)
01/2012
1Diabetes Complications
01/2012
1Liver Neoplasms (Liver Cancer)
06/2010
1Chronic Hepatitis B
02/2010
1Hepatitis C
02/2010
1Burns
10/2009
1Infections
10/2009
1Urinary Tract Infections (Urinary Tract Infection)
10/2009
1Insulin Resistance
01/2009
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2009
1Breast Neoplasms (Breast Cancer)
10/2008
1Leukemia
10/2008
1Hyperlipidemias (Hyperlipidemia)
08/2008

Drug/Important Bio-Agent (IBA)

3TubulinIBA
06/2009 - 10/2008
2AntigensIBA
05/2019 - 01/2019
2XenobioticsIBA
01/2017 - 11/2014
2Pharmaceutical PreparationsIBA
06/2010 - 10/2008
2Blood Glucose (Blood Sugar)IBA
02/2010 - 01/2009
2Insulin ReceptorIBA
02/2010 - 01/2009
2Insulin (Novolin)FDA Link
02/2010 - 01/2009
2BerberineIBA
02/2010 - 01/2009
2LigandsIBA
02/2009 - 10/2008
1Cytotoxins (Cytolysins)IBA
11/2021
1RNA Splicing FactorsIBA
11/2021
1RNA (Ribonucleic Acid)IBA
11/2021
1RNA Precursors (Precursor, mRNA)IBA
11/2021
1Biomarkers (Surrogate Marker)IBA
04/2020
1SincalideFDA Link
08/2019
1AutoantibodiesIBA
05/2019
1Monoclonal AntibodiesIBA
05/2019
1Alanine (L-Alanine)FDA Link
05/2019
1Complement Factor H (Factor H)IBA
05/2019
1Peptides (Polypeptides)IBA
05/2019
1ElementsIBA
01/2019
1Synephrine (Oxedrine)IBA
09/2018
1Galectin 3 (LGALS3)IBA
09/2018
1SPA70IBA
01/2017
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2016
1Pregnane X ReceptorIBA
11/2014
1squaric acidIBA
07/2013
1fosbretabulin (combretastatin A4)IBA
07/2013
1NAD (NADH)IBA
01/2012
1Vincristine (Oncovin)FDA LinkGeneric
06/2010
1Paclitaxel (Taxol)FDA LinkGeneric
06/2010
1SynucleinsIBA
06/2010
1Glucose (Dextrose)FDA LinkGeneric
02/2010
1Triglycerides (Triacylglycerol)IBA
02/2010
1Hemoglobin AIBA
02/2010
1vertilmicinIBA
10/2009
1Protein Kinase CIBA
01/2009
1Messenger RNA (mRNA)IBA
01/2009
1N- (2,6- dimethoxypyridine- 3- yl)- 9- methylcarbazole- 3- sulfonamideIBA
10/2008
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2008
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2008
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2008

Therapy/Procedure

3Therapeutics
01/2019 - 08/2008
1Immunotherapy
01/2019
1Drug Therapy (Chemotherapy)
06/2010